USA Compression names Jim Holotik director on Form 3

USA Compression Partners, LP filed a Form 3 identifying Jim Holotik as a director of the partnership.

Rhea-AI Filing Summary

USA Compression Partners, LP filed a Form 3 identifying Jim Holotik as a director of the partnership. The filing reports no common stock or derivative transactions, and no derivative positions, serving as an initial insider ownership statement without activity details.

Key Figures

Buy transactions: 0 Sell transactions: 0 Derivative transactions: 0 +1 more

4 metrics

Buy transactions 0 Form 3 transaction summary for Jim Holotik

Sell transactions 0 Form 3 transaction summary for Jim Holotik

Derivative transactions 0 Form 3 derivative transaction count

Net buy/sell direction neutral Form 3 netBuySellDirection field

Key Terms

Form 3, derivative positions, Rule 10b5-1 trading plans

3 terms

Form 3 regulatory

"INSIDER FILING DATA (Form 3): initial statement for insiders"

Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.

derivative positions financial

"derivativeSummary contains remaining derivative positions"

Derivative positions are contracts that derive their value from an underlying asset—such as a stock, bond, currency or commodity—and include instruments like options, futures and swaps. Think of them as bets or insurance tied to an asset’s future price: they let investors amplify returns, hedge risk or take exposure without owning the asset directly, which can meaningfully increase potential gains, losses and volatility in a portfolio.

Rule 10b5-1 trading plans regulatory

"Footnotes may reference Rule 10b5-1 trading plans"

Rule 10b5-1 trading plans are written, pre-arranged instructions that allow company insiders (such as executives or directors) to automatically buy or sell their company's stock at specified times or under set conditions, like a standing instruction or automated thermostat for trades. They matter to investors because these plans provide a legal defense against insider‑trading accusations and create predictable insider trading patterns that can help signal whether sales are routine portfolio management or potentially meaningful to the company’s outlook.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does USA Compression Partners, LP's Form 3 for Jim Holotik show?

The Form 3 for Jim Holotik identifies him as a director of USA Compression Partners, LP. The data provided shows no reported transactions, exercises, gifts, tax withholdings, or derivative positions associated with him in this initial statement.

Are any stock transactions reported for Jim Holotik in USAC's Form 3?

No transactions are reported for Jim Holotik in this Form 3. The transaction summary lists zero buys, sells, exercises, gifts, or tax withholdings, indicating no trading activity is disclosed in this initial beneficial ownership filing.

Does the USAC Form 3 show any derivative positions for Jim Holotik?

The Form 3 data shows no derivative positions for Jim Holotik. The derivative summary is empty and the derivative transaction count is zero, meaning no options, warrants, or similar instruments are listed in this filing.

What does the transaction summary indicate in the USAC Form 3?

The transaction summary indicates no activity for Jim Holotik. Buy, sell, exercise, gift, tax withholding, and restructuring counts and share amounts are all zero, and the net buy/sell direction is described as neutral in this filing.

What insider role does Jim Holotik hold at USA Compression Partners, LP?

The Form 3 identifies Jim Holotik as a director of USA Compression Partners, LP. He is not reported as an officer or a ten percent owner in the provided data, and no additional roles are specified in this filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/30/2026 - 08:14 PM EDT Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Holotik Jim

(Last) (First) (Middle)

C/O USA COMPRESSION PARTNERS, LP

8115 PRESTON ROAD, SUITE 700

(Street)

DALLAS TEXAS 75225

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
04/28/2026

3. Issuer Name and Ticker or Trading Symbol
USA Compression Partners, LP [ USAC ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

The Reporting Person is a director of USA Compression GP, LLC, the general partner (the "General Partner") of USA Compression Partners, LP (the "Issuer"). The Issuer is managed by the directors and executive officers of the General Partner. Exhibit List: Exhibit 24- Power of Attorney.

No securities are beneficially owned.

	/s/ Rachel D. Evans, as attorney-in-fact for Jim S. Holotik	04/30/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)